Skip to main content
. 2012 Nov 24;31(1):79–138. doi: 10.1016/j.ncl.2012.09.008

Table 13.

Managing the urinary dysfunction following transverse myelitis

Treatment Options Comments
Detrusor hyperreflexia (failure to store)
  • Anticholinergic agents (eg, trospium, fesoterodine, oxybutynin, tolterodine)

  • Selective M2- and M3-antimuscarinics (darifenacin and solifenacin)

Common side effects include dry mouth and constipation. Contraindicated in patients with angle-closure glaucoma and mechanical bladder outlet obstruction.
Nonselective agents should be used cautiously, if at all, in patients with cognitive dysfunction.
  • Intravesical atropine, oxybutinin, capsaicin, or resiniferatoxin

  • Detrusor muscle botulinum toxin A injection

  • Suprapubic vibration ("Queen Square bladder stimulator")

Detrusor-sphincter dyssynergia
  • Alpha-1 adrenergic antagonists (eg, tamsulosin)

  • Clean intermittent catheterization (CIC)

  • Suprapubic vibration ("Queen Square bladder stimulator")

  • Neuromodulation (InterStim)

  • Intrasphincteric botulinum toxin

  • Indwelling Foley catheter

  • Suprapubic catheter

Alpha antagonists may cause hypotension, tachycardia, and bladder incontinence, particularly in those patients with coincident bladder spasms.
CIC should be considered if postvoid residual volume exceeds 100 mL.
Patients with sacral nerve stimulators cannot undergo MRIs.
Indwelling Foley catheters are contraindicated in females.
Frequent urinary tract infections Appropriate antibiotics
Prophylactic antibiotic therapy
Cranberry preparations
Vitamin C supplementation
Cystoscopic evaluation may be needed to look for bladder trabeculations that serve as a nidus for infections.
Painful bladder spasms Pharmacotherapy
Timed voiding
Neuromodulation
Pharmacotherapy: baclofen, benzodiazepines, hyoscine butylbromide, gabapentin and cannabinoids.
Nocturia Behavioral measures
Pelvic floor exercises
Imipramine
Desmopressin (DDAVP)
Bladder rehabilitation
Avoid alcoholic and caffeinated beverages after 5 pm, to limit fluid intake in the evening, to avoid any fluids 2 h before bedtime and to void before going to bed.

Data from Refs.3, 297, 298, 458, 459, 460, 461, 462, 463, 464, 465